Search by Drug Name or NDC

    NDC 15370-0305-04 POKONZA 0.75 g/.79g Details

    POKONZA 0.75 g/.79g

    POKONZA is a ORAL POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Carwin Pharmaceutical Associates, LLC. The primary component is POTASSIUM CHLORIDE.

    Product Information

    NDC 15370-0305
    Product ID 15370-305_aaccd6e8-7c06-409f-be77-2b1384ec63b3
    Associated GPIs
    GCN Sequence Number 085305
    GCN Sequence Number Description potassium chloride PACKET 10 MEQ ORAL
    HIC3 C1D
    HIC3 Description POTASSIUM REPLACEMENT
    GCN 54758
    HICL Sequence Number 000549
    HICL Sequence Number Description POTASSIUM CHLORIDE
    Brand/Generic Brand
    Proprietary Name POKONZA
    Proprietary Name Suffix n/a
    Non-Proprietary Name Potassium Chloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 0.75
    Active Ingredient Units g/.79g
    Substance Name POTASSIUM CHLORIDE
    Labeler Name Carwin Pharmaceutical Associates, LLC
    Pharmaceutical Class Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208019
    Listing Certified Through 2024-12-31

    Package

    NDC 15370-0305-04 (15370030504)

    NDC Package Code 15370-305-04
    Billing NDC 15370030504
    Package 4 POUCH in 1 CARTON (15370-305-04) / .79 g in 1 POUCH (15370-305-01)
    Marketing Start Date 2023-09-19
    NDC Exclude Flag N
    Pricing Information N/A